Dergiler / Turkish journal of emergency medicine (Online) / 2022 / Cilt: 22 - Sayı: 3

Use of stroke scales in clinical practice: Current concepts

Sayfa
119–124
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In future, the use of composite rating scales could be useful for a detailed measurement of neurological deficits in acute stroke and better assess the efficacy of a treatment and functional outcome.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:With stroke being the leading global cause of disability in adults, the use of clinical rating scales in stroke patients is important not only for diagnostic and therapeutic purposes but also for prognostic and care implications.
📊
Temel Bulgular & Veri:In acute stroke, it is that in most cases, the scales evaluate a neurological deficit attributable to an alteration of the anterior and not posterior circulation and most of them assess a moderate stroke rather than a mild or severe one.
💡
Sonuç & Katkı:In future, the use of composite rating scales could be useful for a detailed measurement of neurological deficits in acute stroke and better assess the efficacy of a treatment and functional outcome.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

With stroke being the leading global cause of disability in adults, the use of clinical rating scales in stroke patients is important not only for diagnostic and therapeutic purposes but also for prognostic and care implications. Scales that quantify neurological disability can be particularly useful for assessing and guiding decisions in acute management and rehabilitative treatment. We analyzed and discussed some of the main rating scales most used in stroke in clinical practice, which measure both acute neurological deficit and functional outcome in stroke. In acute stroke, it is that in most cases, the scales evaluate a neurological deficit attributable to an alteration of the anterior and not posterior circulation and most of them assess a moderate stroke rather than a mild or severe one. In a rehabilitation treatment, they are sometimes too simplified; thus, the patient can reach a near‑normal score and can have significant cognitive deficits that can affect both the possibility of communication and the reliability of responses. A patient with autonomy in the activities of daily living may not be completely autonomous. In future, the use of composite rating scales could be useful for a detailed measurement of neurological deficits in acute stroke and better assess the efficacy of a treatment and functional outcome.

🔖

Bu Makaleye Atıf Yap

SİNİSCALCHİ, A. (2022). Use of stroke scales in clinical practice: Current concepts. Turkish journal of emergency medicine (Online), Cilt: 22 - Sayı: 3, 119–124. https://ajindex.com/articles/414163

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. W H O. N o v e l C o r o n a v i r u s – C h i n a; J a n u a r y 1 2, 2 0 2 0. A v a i l a b l e f r o m: h t t p: / / w w w. w h o. i n t / c s r / don/12‑january‑2020‑novel‑coronavirus‑china/en/. [Last accessed on 2020 Jan 19]
  2. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92:401‑2
  3. WHO. Novel Coronavirus – Thailand (ex‑China); January 14, 2020. Available from: http://www.who.int/csr/ don/14‑january‑2020‑novel‑coronavirusthailand/en/. [Last accessed on 2020 Jan 19]
  4. WHO. Novel Coronavirus – Japan (ex‑China); January 17, 2020. Available from: http://www.who.int/csr/ don/17‑january‑2020‑novel‑coronavirusjapan‑ex‑china/ en/. [Last accessed on 2020 Jan 19]
  5. CDC. First Travel‑Related Case of 2019 Novel Coronavirus Detected in United States; January 21, 2020. Available f r o m: h t t p s: / / w w w. c d c. g o v / m e d i a / r e l e a s e s / 2 0 2 0 / p0121‑novel‑coronavirus‑travel‑case.html. [Last accessed on 2020 Jan 23]
  6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507‑13
  7. WHO. Clinical Management of Severe Acute Respiratory İnfection When Novel Coronavirus (nCoV) İnfection is Suspected: İnterim Guidance; January 11, 2020. Available from: https://www.who. int/internalpublications‑detail/clinical‑management‑of‑severe‑ acute‑respiratoryinfection‑when‑novel‑coronavirus‑(ncov)‑infe ction‑is‑suspected. [Last accessed on 2020 Jan 20]
  8. WHO. 2019‑nCoV Outbreak: First Cases Confirmed in Europe. Available from: https://www.euro.who.int/en/health‑topics/ health‑emergencies/novel‑coronavirus‑2019‑ncov_old. [Last accessed on 2020 Feb 20]
  9. WHO Coronavirus Disease (COVID‑19) Dashboard. Available from: https://covid19.who.int/. [Last updated on 2021 Jan 09]
  10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708‑20
  11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‑ınfected pneumonia. N Engl J Med 2020;382:1199‑207
  12. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID‑19: Evidence from meta‑analysis. Aging (Albany NY) 2020;12:6049‑57
  13. Ludvigsson JF. Systematic review of COVID‑19 in children sho